Every few months a science story is flattened into a miracle. In late 2025, researchers at the Japan Advanced Institute of Science and Technology (JAIST) reported in Gut Microbes that Ewingella americana, a bacterium isolated from the gut of a Japanese tree frog, cleared experimental colorectal tumours in a small mouse group after a single intravenous dose. Press summaries leaned hard on “100% complete response”. That figure describes a specific preclinical model with a handful of animals — not a clinic, not a pharmacy shelf, and not a human trial result.
Viral posts often skip the boring parts. The tumours were a mouse cell-line model, not ordinary human bowel cancer with years of mutations and prior treatment. E. americana is a live Gram-negative organism that has, in rare cases, been linked to serious infections in people. Independent replication, safer formulations and regulated human studies would still have to happen before anyone could call this a therapy. As of mid-2026, that path had not been presented as an approved medicine.
Why this belongs on a scam-awareness site: miracle biology is catnip for follow-on pitches. Expect “early access” clubs, tokenised “biotech” drops, Telegram mentors selling “protocols”, or donation drives that borrow a journal title and invent a waiting list. None of that is how legitimate clinical development works. Check the actual paper or the institute press note, ask whether human trials are registered, and treat anyone demanding crypto or wire fees for a frog-bacteria cure as a salesperson, not a scientist.
Curiosity about the research is fine. Paying a stranger to jump the queue is not.
If a medical or investment pitch already cost you money, start at Get help. Recovery cold-calls after a “breakthrough” story are common — read Fake recovery before you send more.
This article is for general information only. It is not legal or financial advice. Details change. If you have lost money, contact your bank or card issuer and use the routes on the help pages.